BiotechTube
Home/Thetis Pharmaceuticals/Gary Mathias
GM

Gary Mathias

Co-Founder and CEO

Thetis Pharmaceuticals

Therapeutic Areas

Gastroenterology (IBD)Oncology

Thetis Pharmaceuticals Pipeline

DrugIndicationPhase
TP-317Ulcerative Colitis (Inflammatory Bowel Disease)Phase 1b

Leadership Team at Thetis Pharmaceuticals

JP
John Parkinson, PhD
Chief Science Officer
JS
Joyce Steinberg, MD, FACP
Chief Medical Officer
BP
Beverly Paperiello
SVP, Development Operations
View full Thetis Pharmaceuticals profile